Get started
Author

Timothy J. Kotzé

Observed names: Kotzé, Timothy J., Timothy J. Kotze
ORCID: 0000-0001-5786-940X
Observed ORCID: 0000-0001-5786-940X
OpenAlex ID: A5083242573
AI is a viable alternative to high throughput screening: a 318-target study
2024 · The Atomwise AIMS Program, Izhar Wallach, et al. · Scientific Reports · 133
Vitamin in the Crosshairs: Targeting Pantothenate and Coenzyme A Biosynthesis for New Antituberculosis Agents
2020 · Hailey S. Butman, Timothy J. Kotzé, et al. · Frontiers in Cellular and Infection Microbiology · 37
PDF
Synthesis and antimicrobial study of organoiridium amido-sulfadoxine complexes
2020 · Timothy J. Kotzé, Sandra Duffy, et al. · Inorganica Chimica Acta · 10
Author Correction: AI is a viable alternative to high throughput screening: a 318-target study
2024 · The Atomwise AIMS Program, Izhar Wallach, et al. · Scientific Reports · 3
PDF
Metabolic Activation versus Masked Prodrugs: Bisubstrate Mimic Inhibitors of CoaBC’s PPCS Activity in Mycobacterium tuberculosis and Staphylococcus aureus
2025 · Timothy J. Kotzé, Konrad J. Mostert, et al. · ACS Infectious Diseases · 2
PDF
The Plasmodium falciparum PPCS is a unique heteromeric complex with prokaryote-like activity and is a target of pantothenate analogs
2026 · Xiangning Liu, Ruitao Jin, et al. · Science Advances
PDF
CCDC 1949937: Experimental Crystal Structure Determination
2020 · Kotzé, Timothy J., Duffy, Sandra, et al. · The Cambridge Structural Database
Synthesis and study of sulfonamide containing organometallic complexes as inhibitors for infectious disease
2019 · Timothy J. Kotze · SUNScholar (Stellenbosch University)
Works count: 8
Citation count: 185
H-index: 3
I10-index: 3
Year
Topic
Type